Showing results (3721-3730 of 8,098) with videos related to
Sort By:
Pageof 810
Current Medicinal Chemistry|April 9, 2015
Cancer drug discovery targeting histone methyltransferases: an updateHongyu Zhao, Ying Wang, Huanqiu LiCurrent Medicinal Chemistry|April 9, 2015
Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression ProfilingGiovanna Morello, Francesca Luisa Conforti, Rosalba Parenti, et al.Current Medicinal Chemistry|April 9, 2015
Insights into Ecto-5'-Nucleotidase as a New Target for Cancer Therapy: A Medicinal Chemistry StudyPatricia Frasson Corbelini, Fabrício Figueiró, Gustavo Machado das Neves, et al.Current Medicinal Chemistry|July 3, 2020
NMR Spectroscopy in the Conformational Analysis of Peptides: An OverviewMarian Vincenzi, Flavia Anna Mercurio, Marilisa LeoneCurrent Medicinal Chemistry|April 17, 2015
Cardiovascular effects of methotrexate in rheumatoid arthritis revisitedTatyana V Popkova, Diana S Novikova, Armen Yuri Gasparyan, et al.Current Medicinal Chemistry|July 14, 2012
DNA repair and resistance to topoisomerase I inhibitors: mechanisms, biomarkers and therapeutic targetsM Alagoz, D C Gilbert, S El-Khamisy, et al.Current Medicinal Chemistry|July 14, 2012
Cancer resistance to type II topoisomerase inhibitorsP Pilati, D Nitti, S MocellinCurrent Medicinal Chemistry|June 26, 2012
The use of therapeutic peptides to target and to kill cancer cellsR J Boohaker, M W Lee, P Vishnubhotla, et al.Current Medicinal Chemistry|July 27, 2012
Developing ROS scavenging agents for pharmacological purposes: recent advances in design of manganese-based complexes with anti-inflammatory and anti- nociceptive activityD Bani, A BenciniCurrent Medicinal Chemistry|July 27, 2012
(Iso)flav(an)ones, chalcones, catechins, and theaflavins as anticarcinogens: mechanisms, anti-multidrug resistance and QSAR studiesAndrew G Mercader, Alicia B PomilioPageof 810